Total Payments
$379,658
2024 Payments
$35,600
Companies
2
Transactions
96
Medicare Patients
3,692
Medicare Billing
$402,361
Payment Breakdown by Category
Research$334,629 (88.1%)
Consulting$44,800 (11.8%)
Food & Beverage$228.74 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $334,629 | 85 | 88.1% |
| Consulting Fee | $44,800 | 8 | 11.8% |
| Food and Beverage | $228.74 | 3 | 0.1% |
Payments by Type
Research
$334,629
85 transactions
General
$45,029
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. | $334,858 | 88 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $44,800 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,600 | 8 | JAZZ PHARMACEUTICALS INC. ($21,600) |
| 2023 | $75,304 | 18 | Vanda Pharmaceuticals Inc. ($52,104) |
| 2022 | $44,000 | 11 | Vanda Pharmaceuticals Inc. ($44,000) |
| 2021 | $48,000 | 12 | Vanda Pharmaceuticals Inc. ($48,000) |
| 2020 | $48,076 | 13 | Vanda Pharmaceuticals Inc. ($48,076) |
| 2019 | $48,049 | 13 | Vanda Pharmaceuticals Inc. ($48,049) |
| 2018 | $48,000 | 12 | Vanda Pharmaceuticals Inc. ($48,000) |
| 2017 | $32,629 | 9 | Vanda Pharmaceuticals Inc. ($32,629) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $1,000.00 | Research |
| 10/08/2024 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $5,000.00 | Research |
| 09/06/2024 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 08/08/2024 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $11,600.00 | General |
| 03/18/2024 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 02/07/2024 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 01/17/2024 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 01/03/2024 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| 12/13/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 12/06/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 12/03/2023 | Jazz Pharmaceuticals Inc. | JZP-441 | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| 11/15/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 10/03/2023 | Jazz Pharmaceuticals Inc. | JZP-441 | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 09/26/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 09/06/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 09/03/2023 | Jazz Pharmaceuticals Inc. | JZP-441 | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 08/16/2023 | Jazz Pharmaceuticals Inc. | JZP-441 | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/12/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 06/21/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 05/17/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 04/19/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 03/08/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 02/08/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| 01/13/2023 | Vanda Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $104.06 | General |
| 01/11/2023 | Vanda Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 583 | 623 | $234,170 | $51,921 |
| 2022 | 10 | 1,225 | 1,360 | $530,555 | $141,334 |
| 2021 | 11 | 1,104 | 1,206 | $467,078 | $131,210 |
| 2020 | 9 | 780 | 854 | $288,531 | $77,897 |
Total Patients
3,692
Total Services
4,043
Medicare Billing
$402,361
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 190 | 208 | $80,185 | $20,467 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $37,309 | $7,249 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $24,474 | $6,119 | 25.0% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 98 | 99 | $24,363 | $5,451 | 22.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 70 | 76 | $22,036 | $3,833 | 17.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $10,064 | $2,847 | 28.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 77 | 89 | $18,506 | $2,608 | 14.1% |
| 67335 | Placement of adjustable sutures during eye muscle surgery | Facility | 2023 | 11 | 11 | $7,626 | $1,931 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $7,501 | $1,155 | 15.4% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 13 | 13 | $2,106 | $261.43 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 343 | 437 | $154,261 | $47,995 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 168 | 168 | $90,384 | $23,728 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 88 | 88 | $58,960 | $17,180 | 29.1% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 269 | 269 | $64,291 | $16,097 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 75 | 76 | $36,100 | $12,494 | 34.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 121 | 142 | $44,446 | $8,527 | 19.2% |
| 67311 | Realignment of horizontal eye muscle | Facility | 2022 | 13 | 13 | $42,548 | $7,388 | 17.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 114 | 129 | $27,219 | $4,303 | 15.8% |
| 67335 | Placement of adjustable sutures during eye muscle surgery | Facility | 2022 | 18 | 18 | $10,926 | $3,176 | 29.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 20 | $1,420 | $445.84 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 304 | 378 | $129,654 | $42,009 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 152 | 152 | $79,344 | $22,546 | 28.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 88 | 88 | $57,200 | $17,086 | 29.9% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 227 | 227 | $52,437 | $14,045 | 26.8% |
| 67311 | Realignment of the eye with repair of one horizontal eye muscle | Facility | 2021 | 14 | 15 | $44,569 | $11,394 | 25.6% |
About Dr. Marc Levin, MD
Dr. Marc Levin, MD is a Ophthalmology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1811123441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Levin, MD has received a total of $379,658 in payments from pharmaceutical and medical device companies, with $35,600 received in 2024. These payments were reported across 96 transactions from 2 companies. The most common payment nature is "" ($334,629).
As a Medicare-enrolled provider, Levin has provided services to 3,692 Medicare beneficiaries, totaling 4,043 services with total Medicare billing of $402,361. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Palo Alto, CA
- Active Since 06/10/2009
- Last Updated 05/29/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1811123441
Products in Payments
- JZP-441 $23,200
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Palo Alto
Darius Moshfeghi, Md, MD
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Emily Charlson, Md, MD
Ophthalmology — Payments: $143,528
Ophthalmology $143,528
Dr. Anurag Shrivastava, Md, MD
Ophthalmology — Payments: $47,582
Ophthalmology $47,582
Neil Friedman, Md, MD
Ophthalmology — Payments: $34,067
Ophthalmology $34,067
Dr. Harvey Fishman, M.d, M.D
Ophthalmology — Payments: $25,268
Ophthalmology $25,268
Dr. Jessica Chen, M.d, M.D
Ophthalmology — Payments: $3,614
Ophthalmology $3,614